Metformin hydrochloride for medulloblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Feb 2022: Trial registered, NCT05230758
  2. 1 Jul 2022: Trial started, NCT05230758

The trials

NCT05230758: Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour

State
Under way
Phase
Phase 3
People
140 planned
Started
1 Jul 2022
Primary completion
30 Nov 2027
Arms
Metformin
Results
None posted
  1. 9 Feb 2022: Trial registered
  2. 1 Jul 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Apophage, Benofomin, Diabefagos, Diabex, Extended Release Metformin Hydrochloride, Fortamet, Glucaminol, Glucophage, Glucophage xr, Glucovance component metformin hydrochloride, Glumetza, Invokamet component metformin hydrochloride, Janumet component metformin hydrochloride, Kazano component metformin hydrochloride, Metformin XR, Metformin hydrochloride (HCl) 500mg tablet, Neodipa, Qternmet component metformin hydrochloride, Qternmet xr component metformin hydrochloride, Riomet, Riomet er, Segluromet component metformin hydrochloride, Siamformet, Trijardy xr component metformin hydrochloride, Walaphage, Xigduo component metformin hydrochloride, Zituvimet component metformin hydrochloride.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.